DK214479A - Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner - Google Patents

Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner

Info

Publication number
DK214479A
DK214479A DK214479A DK214479A DK214479A DK 214479 A DK214479 A DK 214479A DK 214479 A DK214479 A DK 214479A DK 214479 A DK214479 A DK 214479A DK 214479 A DK214479 A DK 214479A
Authority
DK
Denmark
Prior art keywords
diamono
hydroxybenzyl
pyrimidines
dialkyl
preparing
Prior art date
Application number
DK214479A
Other languages
English (en)
Inventor
S R M Bushby
J J Burchall
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK214479A publication Critical patent/DK214479A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK214479A 1978-05-24 1979-05-23 Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner DK214479A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2193878 1978-05-24

Publications (1)

Publication Number Publication Date
DK214479A true DK214479A (da) 1979-11-25

Family

ID=10171323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK214479A DK214479A (da) 1978-05-24 1979-05-23 Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner

Country Status (12)

Country Link
EP (1) EP0006987A1 (da)
JP (1) JPS54154775A (da)
AU (1) AU4732579A (da)
DK (1) DK214479A (da)
FI (1) FI791638A (da)
IL (1) IL57375A0 (da)
IT (1) IT1117752B (da)
MA (1) MA18450A1 (da)
MC (1) MC1264A1 (da)
NO (1) NO791699L (da)
PT (1) PT69656A (da)
ZW (1) ZW9979A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK523781A (da) * 1980-11-27 1982-05-28 Wellcome Found Fremgangsmaade til fremstilling af benzylpyrimidiner samt mellemprodukt for disse
HU188588B (en) * 1982-08-13 1986-04-28 Egyt Gyogyszervegyeszeti Gyar Process for the production of 2,4-diamino-5-benzyl-pyrimidine-derivatives
FR2652812A1 (fr) * 1989-10-09 1991-04-12 Rhone Poulenc Chimie Procede de preparation de difluoro-2,2 benzodioxole-1,3.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB875562A (en) * 1957-02-21 1961-08-23 Wellcome Found Improvements in and relating to pyrimidine derivatives and the preparation thereof
GB1128234A (en) * 1966-02-19 1968-09-25 Wellcome Found 5-benzylpyrimidine derivatives and process for the preparation thereof
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3684810A (en) * 1970-03-11 1972-08-15 Hoffmann La Roche Process for 2,4-diamino-5-(3,5-dimethoxy-4-hydroxybenzyl) pyrimidine
GB1375162A (da) * 1970-10-22 1974-11-27
BE789904A (fr) * 1971-10-12 1973-04-10 Wellcome Found Procedes de synthese organique
GB1413472A (en) * 1971-10-12 1975-11-12 Wellcome Found 2,4-diamino pyrimidines
DE2546667C3 (de) * 1975-10-17 1978-10-12 Ludwig Heumann & Co Gmbh, 8500 Nuernberg 2,4-DiamüH»-5-(3-methoxy-4-hydroxy-5-halogenbenzyl)-pyrimidine, und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL57375A0 (en) 1979-09-30
NO791699L (no) 1979-11-27
PT69656A (en) 1979-06-01
MA18450A1 (fr) 1979-12-31
EP0006987A1 (en) 1980-01-23
FI791638A (fi) 1979-11-25
MC1264A1 (fr) 1980-03-28
JPS54154775A (en) 1979-12-06
ZW9979A1 (en) 1980-12-24
AU4732579A (en) 1979-11-29
IT7949150A0 (it) 1979-05-23
IT1117752B (it) 1986-02-24

Similar Documents

Publication Publication Date Title
DK153552C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinderivater
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK149023C (da) Analogifremgangsmaade til fremstilling af tiazolidinderivater
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK469379A (da) Fremgangsmaade til fremstilling af 1-hydroxylerede 5,6-vitamind-forbindelser
DK153844C (da) Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
DK152138C (da) Fremgangsmaade til fremstilling af urokinase
DK117779A (da) Fremgangsmaade til fremstilling af 2,6-dialkoxybenzamider
DK153379A (da) Fremgangsmaade til fremstilling af n,n,n!,n!-tetraacetylethylendiamin
DK311779A (da) Fremgangsmaade til fremstilling af spaanplader
DK400381A (da) Fremgansmaade til fremstilling af penicillanoyloxymethyl-penicillanoyloxymethyl-penicillanat-1,1,1!,1!-tetraoxid
DK159681A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer
DK161198C (da) Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
DK156635C (da) Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK301277A (da) Fremgangsmade til fremstilling af substituerede 2,6-methano-2h-1-benzoxociner
DK153838C (da) Analogifremgangsmaade til fremstilling af 2,4-dichlor-alfa-(n-imidazolylmethyl)-dibenzylethere
DK73077A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo (4,3,1,03,7) decaner
DK365879A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2h (1) benzotheno(,3-)-1,2-thiazin-3-carboxamid-1,1-dioxider
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
DK40479A (da) Fremgangsmaade til fremstilling af monorden
DK214479A (da) Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner
DK250679A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin